Arcutis Biotherapeutics, Inc. ARQT Net debt
Discontinued — last reported Q1 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Arcutis Biotherapeutics, Inc.’s reported figures.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s net debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s net debt?
- Arcutis Biotherapeutics, Inc. (ARQT) reported net debt of $79.6M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s net debt changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s net debt increased by 39.5% year-over-year, from $57.08M to $79.6M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s net debt?
- Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s net debt has grown at a 2.9% compound annual growth rate (CAGR), from -$61.66M to $71.3M.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.